PPH · VanEck Pharmaceutical ETF

Equity fundTracks an index0.36% fee$879m on Jun 30, 2026SEC filings ↗

PPH tracks an index and returned +20.6% over the past year.

+20.6%
Total return, 1 year
0.36%
Expense ratio
25
Holdings
−6.0%
Below its high since Jan 4, 2010
2.3%
12-month yield: cash paid, 1 year, on its starting price
$0.36
Last payment (paid quarterly), ex-date Oct 1, 2026

Points (pts) are percentage points.

WindowTotal returnS&P 500 (SPY)Gap to SPY
1M Sep 9 – Oct 9, 2026+0.7%+2.4%−1.7 pts
3M Jul 10 – Oct 9, 2026+1.9%+3.4%−1.5 pts
6M Apr 10 – Oct 9, 2026+7.4%+15.2%−7.8 pts
YTD Dec 31, 2025 – Oct 9, 2026+8.9%+15.1%−6.1 pts
1Y Oct 9, 2025 – Oct 9, 2026+20.6%+17.3%+3.4 pts
3Y Oct 10, 2023 – Oct 9, 2026+46.3%+85.8%−39.5 pts

Total return at closing prices, distributions reinvested. Every column is a total return. Year to date runs from the last close of the year before. Source: ETFIQ.

PPH top ten by weight, 72.7% of the fund, of its 25 equity positions, from the holdings filed for Jun 30, 2026. That is 101 days before Oct 9, 2026, older than the issuer’s daily file, which ETFIQ could not read. An index fund holds what the index holds, so this is the index. Source: the fund’s SEC filing.

Novartis AG 10.62%
Novo Nordisk A/S 5.37%
GSK PLC 4.42%

In plain words

What it tracksnot read by ETFIQ
Fund typeEquity fund
Category (ETFIQ)Stocks · Health care
Expense ratio (485BPOS XBRL, Jan 27, 2026)0.36%
Price$110.49
First tradednot stated: its price history begins on Feb 1, 2000, but the SEC lists no filing for its series, S000034409, until after Dec 31, 2006, so the prices before then are another security's and its first trade cannot be dated
Net assets (SEC filing, whole fund, as filed for Jun 30, 2026)$879m
Benchmark (ETFIQ, from its filings)Its own holdings, as of Jun 30, 2026; its prospectus names no index it tracks
Below its high since Jan 4, 2010 (ETFIQ)−6.0%
Holdings25
Top ten weight72.7%
Holdings as of (SEC N-PORT)Jun 30, 2026
Already in the S&P 500, by weight (ETFIQ)58.7%
Active share vs the S&P 500 (ETFIQ)95.7%
Already in the Nasdaq-100, by weight (ETFIQ)0.0%

Questions people ask about PPH

How has PPH performed?
Over the year to Oct 9, 2026, PPH returned +20.6% with distributions reinvested, against +17.3% for the S&P 500. Over three years the figure is +46.3%.
What does PPH cost?
The prospectus expense ratio is 0.36% a year.
What does PPH hold?
25 positions as filed for Jun 30, 2026, with the top ten at 72.7% of the fund. 59% of its weight is in stocks the S&P 500 also holds.
How far is PPH below its high?
6.0% below its high of Aug 25, 2026, measured on the reinvested series to Oct 9, 2026.
Sources and dates
Prices, PPH and S&P 500 (SPY)Tiingo end-of-day · Oct 9, 2026
Net assets, $879mSEC filing, whole fund · Jun 30, 2026

ETFIQ links to the documents behind every figure; a link is not an endorsement.

Cite this pageCitation, APA and Markdown

ETFIQ, PPH, stock fund, data as of Oct 9, 2026. https://etfiq.com/funds/pph

Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

Get the weekly ETF note

Four ranked ETF lists in one email every Friday morning. Free, with no recommendations. The last note

Confirm from the link that arrives, and unsubscribe in one click. See Privacy.